Mechanical Ventilation Weaning Protocol in the Coronary Care Unit
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The following objectives were used for comparison: 1) primary objective: reintubation rate during hospitalization; 2) secondary objectives: length of hospitalization at the Coronary Care Unit; time from intubation to start of weaning; time from start of weaning to extubation; time from SBT and extubation; presence of respiratory infection in patients requiring reintubation; mortality of patients requiring reintubation.
| Condition | Intervention |
|---|---|
|
Mechanical Ventilation Cardiomyopathy |
Other: Application of mechanical ventilation weaning protocol |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of the Effects of the Use of Mechanical Ventilation Weaning Protocol in the Coronary Care Unit: A Randomized Study |
- Measure: reintubation rates after mechanical ventilation weaning protocol [ Time Frame: 48 hours after extubation ]
- Duration of mechanical ventilation weaning [ Time Frame: within the first 7 days after indication of mechanical ventilation weaning ]
| Enrollment: | 36 |
| Study Start Date: | March 2006 |
| Study Completion Date: | December 2006 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental group
Application of a weaning mechanical ventilation protocol
|
Other: Application of mechanical ventilation weaning protocol
Application protocol for 8 months in experimental group
|
| No Intervention: Control group |
Other: Application of mechanical ventilation weaning protocol
Application protocol for 8 months in experimental group
|
Detailed Description:
Once the cause leading to the need of MV was resolved, patients from both groups underwent a daily clinical evaluation in the mornings, to determine whether they were ready for mechanical ventilation weaning, according to the following clinical SBT criteria: 1) Cause of MV: resolution of the cause and abnormalities leading to MV; 2) neurological stability: patient awake, without or with minimal infusion of sedatives/narcotics, with effective cough and Glasgow scale ≥ 9; 3) cardiovascular stability: mean blood pressure (MBP) ≥ 60 mm Hg, without vasopressors or with low vasopressor doses, heart rate (HR) ≤ 140 / min, hemoglobin (Hb) ≥ 8,0 - 10,0 g/L, partial arterial oxygen pressure (PaO2) ≥ 60 mm Hg with fraction of inhaled oxygen (FiO2) ≤ 0.4, oxygenation index (PaO2 / FiO2) ≥ 150 - 300 without significant respiratory acidosis; 4) metabolic stability: temperature < 37.8° C (armpit) and lack of hydroelectrolytic disorders.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients hospitalized at the CCU with MV for over 24 hours;
- age over 18 years;
- both genders;
- patients capable of spontaneous ventilation;
- patients with indication for MV weaning.
Exclusion Criteria:
- conditions and/or circumstances that might result in difficulty to understand the informed consent (psychiatric disorder, alcohol or drug addiction, mental disability);
- patient denies to sign the informed consent;
- end-stage diseases and
- dependence on mechanical ventilation.
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00557999 History of Changes |
| Other Study ID Numbers: | CAAE-0009.0.140.000-06, C71050P |
| Study First Received: | November 13, 2007 |
| Last Updated: | November 13, 2007 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Hospital de Base:
|
Cardiology Mechanical ventilation Intensive care |
Additional relevant MeSH terms:
|
Cardiomyopathies Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013